EW Edwards Lifesciences
$86.48 -0.86%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.86%
YTD
+12.70%
P/E
49.27
P/B
4.79
ROE
9.7%
Div yield
—
Beta
0.56
Market cap
$49.5B
RSI (14)
46
Next earnings
Oct 28, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$87.54
Close
$86.48
VWAP (n/a)
—
Day high
$87.88
Day low
$85.94
Volume
3.4M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
Yahoo Finance · Oct 5
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
Yahoo Finance · Oct 1
How Investors May Respond To Edwards Lifesciences (EW) Expanded TAVR Access And Transcatheter Valve Ambitions
Yahoo Finance · Sep 18
Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead
Yahoo Finance · Sep 17
CMS expands TAVR Medicare coverage to asymptomatic patients
Yahoo Finance · Sep 11
Is Edwards Lifesciences Stock Underperforming the Dow?
Yahoo Finance · Sep 8
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 28, 2026 View → 10-Q Aug 4, 2026 View → 8-K Jul 23, 2026 View → 8-K May 8, 2026 View → 10-Q May 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell EW. Try it in the Lab to size a position and see the risk.